Park Avenue Securities’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $881K | Buy |
|
|||||
|
2025
Q2 | $771K | Sell |
|
|||||
|
2025
Q1 | $938K | Sell |
|
|||||
|
2024
Q4 | $1.44M | Buy |
|
|||||
|
2024
Q3 | $1.99M | Buy |
|
|||||
|
2024
Q2 | $1.84M | Buy |
|
|||||
|
2024
Q1 | $1.61M | Buy |
|
|||||
|
2023
Q4 | $1.34M | Buy |
|
|||||
|
2023
Q3 | $1.18M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $802K | Buy |
|
|||||
|
2022
Q3 | $721K | Buy |
|
|||||
|
2022
Q2 | $580K | Buy |
|
|||||
|
2022
Q1 | $601K | Sell |
|
|||||
|
2021
Q4 | $1.03M | Buy |
|
|||||
|
2021
Q3 | $417K | Sell |
|
|||||
|
2021
Q2 | $521K | Sell |
|
|||||
|
2021
Q1 | $523K | Buy |
|
|||||
|
2020
Q4 | $334K | Buy |
|
|||||
|
2020
Q3 | $216K | Buy |
|